Amaroq Therapeutics 'hits early milestones' in cancer treatment
NZ biotech company Amaroq Therapeutics said it is progressing towards clinical trials following a promising initial development phase.
Stay updated with breaking news from Davidl Spector. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
NZ biotech company Amaroq Therapeutics said it is progressing towards clinical trials following a promising initial development phase.
/PRNewswire/ -- Amaroq Therapeutics, a biotechnology company focussed on developing a new class of therapeutics that target lncRNA in cancer, is progressing...
Gene-regulating snippet of RNA may contribute to breast cancer metastasis Cold Spring Harbor Laboratory (CSHL) scientists have discovered a gene-regulating snippet of RNA that may contribute to the spread of many breast cancers. In animal experiments, the researchers could reduce the growth of metastatic tumors with a molecule designed to target that RNA and trigger its destruction. The same strategy, they say, could be used to develop a new breast cancer treatment for patients. The study, led by CSHL Professor and Director of Research David Spector, was reported in the journal Nature Commun...